Trials / Terminated
TerminatedNCT00162786
Comparative Effects of Rupatadine 10 mg, Hydroxyzine 50 mg and Placebo on Actual Driving Performance
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 20 (planned)
- Sponsor
- J. Uriach and Company · Industry
- Sex
- All
- Age
- 21 Years – 35 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to measure and compare the acute effects of rupatadine 10 mg, relative to placebo and hydroxyzine 50 mg as an active control on healthy volunteers' performance on a standard over-the-road driving test and a car-following test.
Detailed description
The study shall be conducted according to a three-way, double-blind, placebo and active controlled crossover design. Treatment groups are identified as follows. * Rupatadine * Hydroxyzine * Placebo
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Rupatadine | |
| DRUG | Hydroxyzine | |
| DRUG | Placebo |
Timeline
- Start date
- 2005-05-01
- Completion
- 2005-11-01
- First posted
- 2005-09-13
- Last updated
- 2006-10-20
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT00162786. Inclusion in this directory is not an endorsement.